E-LIB Suche - Ergebnisse für: Klok, M. D.

1

A common and functional mineralocorticoid receptor haplotyp..:

Klok, M D ; Giltay, E J ; Van der Does, A J W...
Translational Psychiatry. 1 (2011) 12 - p. e62-e62 , 2011

Link: https://doi.org/10.1038/..

2

Rate Acceleration of Light‐Driven Rotary Molecular Motors:

Pollard, M. M. ; Klok, M. ; Pijper, D..
Advanced Functional Materials. 17 (2007) 5 - p. 718-729 , 2007

Link: https://doi.org/10.1002/..

3

The role of leptin and ghrelin in the regulation of food in..:

Klok, M. D. ; Jakobsdottir, S. ; Drent, M. L.
Obesity Reviews. 8 (2006) 1 - p. 21-34 , 2006

Link: https://doi.org/10.1111/..

4

Freezing of gait and major depressive disorder responding b..:

Klok, M. PhC. ; Nonnekes, J. ; Stek, M.L...
Parkinsonism & Related Disorders. 66 (2019) - p. 249-250 , 2019

Link: https://doi.org/10.1016/..

5

Development of an updated, standardized, patient-centered o..:

de Rooij, Belle H. ; van den Hurk, Corina ; Smaardijk, Veerle...
Lung Cancer. 173 (2022) - p. 5-13 , 2022

Link: https://doi.org/10.1016/..

6

Cost-Effectiveness of a 10- Versus 13-Valent Pneumococcal C..:

Klok, Rogier M. ; Lindkvist, Rose-Marie ; Ekelund, Mats..
Clinical Therapeutics. 35 (2013) 2 - p. 119-134 , 2013

Link: https://doi.org/10.1016/..

7

The authors respond:

Klok, Rogier M. ; Lindkvist, Rose-Marie ; Ekelund, Mats..
Clinical Therapeutics. 35 (2013) 7 - p. 1048-1050 , 2013

Link: https://doi.org/10.1016/..

8

Methylnaltrexone bromide for the treatment of opioid‐induce..:

EARNSHAW, S. R. ; KLOK, R. M. ; IYER, S..
Alimentary Pharmacology & Therapeutics. 31 (2010) 8 - p. 911-921 , 2010

Link: https://doi.org/10.1111/..

9

Cost-effectiveness of a potential future Helicobacter pylor..:

de Vries, Robin ; Klok, Rogier M. ; Brouwers, Jacobus R.B.J..
Vaccine. 27 (2009) 6 - p. 846-852 , 2009

Link: https://doi.org/10.1016/..

10

Incremental cost effectiveness of proton pump inhibitors fo..:

Vonkeman, Harald E ; Braakman-Jansen, Louise MA ; Klok, Rogier M...
Arthritis Research & Therapy. 10 (2008) 6 - p. R144 , 2008

Link: https://doi.org/10.1186/..

11

Direct Medical Costs of Serious Gastrointestinal Ulcers amo..:

Vonkeman, Harald E ; Klok, Rogier M ; Postma, Maarten J..
Drugs & Aging. 24 (2007) 8 - p. 681-690 , 2007

Link: https://doi.org/10.2165/..

12

Switch patterns before and after patent expiry of omeprazol..:

KLOK, R. M. ; BOERSMA, C. ; OOSTERHUIS, I....
Alimentary Pharmacology & Therapeutics. 23 (2006) 11 - p. 1595-1600 , 2006

Link: https://doi.org/10.1111/..

13

Economic evaluation of a randomized trial comparinghelicoba..:

Klok, Rogier M. ; Arents, Nicolaas L.A. ; de Vries, Robin...
Clinical Therapeutics. 27 (2005) 10 - p. 1647-1657 , 2005

Link: https://doi.org/10.1016/..

14

Drug Costs Developments after Patent Expiry of Enalapril, F..:

Boersma, Cornelis ; Klok, Rogier M ; Bos, Jasper M...
Applied Health Economics and Health Policy. 4 (2005) 3 - p. 191-196 , 2005

Link: https://doi.org/10.2165/..

15

Pharmacoeconomics of Gastrointestinal Drug Utilisation Prio..:

Klok, Rogier M. ; Van Der Veen, Willem Jan ; Van Der Werf, Ger Th...
Helicobacter. 9 (2004) 1 - p. 87-91 , 2004

Link: https://doi.org/10.1111/..